Gagan Mathur | Medicine and Dentistry Award | Best Researcher Award

Posted on by ScienceFather

Assoc Prof Dr. Gagan Mathur | Medicine and Dentistry Award | Best Researcher Award

Assoc Prof Dr. Gagan Mathur, University of California Irvine, United States

Assoc Prof Dr. Gagan Mathur: Candidate for Best Researcher Award Evaluation

Publication profile

Employment History

Dr. Gagan Mathur is a highly experienced professional with a strong background in transfusion medicine and clinical pathology. Since December 2022, he has served as the Medical Director of Transfusion Medicine-Blood Bank at the University of California Irvine School of Medicine, where he also holds the role of Associate Program Director of the Pathology Residency Program. He has previously held prominent positions at the Children’s Hospital Los Angeles and Saint Luke’s Health System in Kansas City, demonstrating his leadership and expertise in managing complex medical and educational settings.

Post-Graduate Training and Education

Dr. Mathur’s rigorous academic background includes a fellowship in Transfusion Medicine/Blood Banking and a residency in Clinical Pathology at the University of Iowa Hospitals & Clinics. He also holds an MBA from the University of Iowa, which complements his medical expertise with business acumen. His foundational medical education was completed at Dr. S.N. Medical College in India.

Certifications and Licensure

Dr. Mathur is board-certified in both Transfusion Medicine/Blood Banking and Clinical Pathology by the American Board of Pathology. He holds medical licenses in California and previously held licenses in Missouri, Kansas, and Iowa. His certification as a Certified Physician Executive underscores his commitment to leadership in healthcare.

Awards and Distinctions

Dr. Mathur has been recognized for his contributions to medicine with numerous accolades, including being named a Top Pathologist by Best in California Magazine in 2023 and a multiple nominee for the Orange County Physician of Excellence award. His early recognition includes the Paul E. Strandjord Young Investigator Award and an Outstanding Reviewer award from a leading scientific journal.

Teaching and Mentoring

Dr. Mathur is actively involved in teaching and mentoring the next generation of medical professionals. He serves as an Associate Program Director and Chair of the Clinical Competency Committee in the Pathology Residency Program at UC Irvine. He also contributes as a faculty member in various transfusion medicine and blood banking courses for medical students, residents, fellows, and clinical laboratory scientist students.

Publication Top Notes

  • Four postmortem case reports with quantitative detection of the synthetic cannabinoid, 5F-PB-22 (Journal of Analytical Toxicology) – Cited by 206, 2014 🧪📊
  • Antibody testing for COVID-19: can it be used as a screening tool in areas with low prevalence? (American Journal of Clinical Pathology) – Cited by 90, 2020 🦠🔬
  • High clinical suspicion of donor‐derived disease leads to timely recognition and early intervention to treat solid organ transplant‐transmitted lymphocytic choriomeningitis virus (Transplant Infectious Disease) – Cited by 29, 2017 🏥🦠
  • Use of a data warehouse at an academic medical center for clinical pathology quality improvement, education, and research (Journal of Pathology Informatics) – Cited by 25, 2015 📈🧑‍💻
  • Clinical profile and mortality among novel influenza A (H1N1) infected patients: 2009-2010 Jodhpur, Rajasthan pandemic (Journal of the Association of Physicians of India) – Cited by 25, 2013 🏥🌍
  • Antibody testing for COVID-19 (American Journal of Clinical Pathology) – Cited by 7, 2020 🦠🧬
  • Factors influencing platelet clumping during peripheral blood hematopoietic stem cell collection (Transfusion) – Cited by 7, 2017 🩸🔬
  • A clinico-epidemiologic study of neurologic associations and factors related to speech and language delay (National Journal of Community Medicine) – Cited by 7, 2012 🧠🗣️
  • Solutions to technical challenges during therapeutic plasma exchange using the Spectra Optia on a 4 kilogram neonate (Transfusion and Apheresis Science) – Cited by 5, 2018 🍼🩸
  • Streamlined sign-out of capillary protein electrophoresis using middleware and an open-source macro application (Journal of Pathology Informatics) – Cited by 5, 2014 🧬💻
  • A case for a national registry of red blood cell antibodies (Vox Sanguinis) – Cited by 4, 2022 🩸🧾
  • Predicting changes in hemoglobin S after simple transfusion using complete blood counts (Transfusion) – Cited by 3, 2018 🩸🧪
  • A case cluster of lymphocytic choriomeningitis virus transmitted via organ transplantation (Transplantation) – Cited by 2, 2014 🦠🏥


Conclusion

Assoc Prof Dr. Gagan Mathur’s extensive experience, academic background, and leadership roles make him a strong candidate for the Best Researcher Award. His contributions to transfusion medicine, combined with his teaching and mentoring roles, demonstrate a commitment to advancing medical science and education. His recognition by peers and multiple accolades further support his suitability for this prestigious award

Rainer Pooth | Medicine and Dentistry Award | Best Innovation Award

Posted on by ScienceFather

Dr. Rainer Pooth | Medicine and Dentistry Award | Best Innovation Award

Dr. Rainer Pooth, ICAAN GmbH, Germany

Based on the information provided, Dr. Rainer Pooth appears to be a highly suitable candidate for the “Research for Best Innovation Award” in the pharmaceutical and medical industry. Here’s an assessment of his qualifications:

Publication profile

Professional Experience & Leadership

Dr. Pooth has over 20 years of experience in the global pharmaceutical and medical industry, with a strong track record of leadership in multidisciplinary teams at both global and affiliate levels. His roles as Managing Director, Global Head of Medical/Scientific Affairs, and Head of Global Clinical Development demonstrate his ability to lead and innovate in complex, highly regulated environments. His strategic input in global R&D programs, project management, and regulatory affairs underscores his expertise in driving innovation and ensuring successful product development.

Achievements & Expertise

Dr. Pooth’s achievements include multiple approvals of medicinal products and medical devices across key global markets such as the EU, US, Australia, and Asia. He holds more than 35 patents, with a significant portion becoming commercially relevant, highlighting his innovative contributions to the field. His extensive publication record, including over 50 publications in international journals and books, as well as his role as an invited speaker at major scientific congresses, further cements his reputation as a leader in pharmaceutical research and innovation.

Global Impact & Collaboration

Dr. Pooth’s global network of experts and key opinion leaders, along with his experience in managing international submission teams and regulatory interactions, illustrates his ability to navigate and influence the global pharmaceutical landscape. His leadership in directing high-level global teams and managing collaborations with regulatory authorities and contract research organizations (CROs) demonstrates his capability to bring innovative products to market successfully.

Publication Top Notes

  • “Treatment of Refractory Cardiac Arrest by Controlled Reperfusion of the Whole Body” – A study exploring CARL in a multicenter setting, highlighting its impact on refractory cardiac arrest patients (2023).
  • “The Impact of Head Position on Neurological and Histopathological Outcome Following CARL” – Investigates how head positioning affects outcomes in a pig model during CARL (2023).
  • “Extracorporeal Cardiopulmonary Resuscitation—Evidence and Implications” – Discusses ECPR’s evidence base and its clinical implications (2023).
  • “Effects of Prolonged Serum Calcium Suppression during ECPR in Pigs” – Examines the effects of serum calcium suppression during ECPR, showing implications for treatment strategies (2023).
  • “Limiting Calcium Overload after Cardiac Arrest” – Focuses on the role of albumin in reducing calcium overload during CARL (2023).
  • “Pervasive Platelet Secretion Defects in SARS-CoV-2 Patients” – Analyzes platelet defects in COVID-19 patients and their potential implications for treatment (2023).
  • “CARL – Controlled Reperfusion of the Whole Body” – A book detailing the CARL procedure, providing a comprehensive resource for clinicians (2022).
  • “Observational Study on Implications of the COVID-19-Pandemic for Cardiopulmonary Resuscitation” – Examines the pandemic’s impact on resuscitation practices, offering valuable insights (2022).
  • “Monitoring Mitochondrial Partial Oxygen Pressure During Cardiac Arrest and ECPR” – A pilot study exploring mitochondrial oxygen monitoring during cardiac arrest in a pig model (2021).
  • “Brain Vulnerability and Viability after Ischaemia” – A review on the neurological outcomes following ischemic events, highlighting vulnerabilities and potential treatment avenues (2021).

Conclusion

Dr. Pooth’s extensive experience, significant contributions to the development and approval of innovative pharmaceutical products, and his leadership in global research and development make him a strong candidate for the “Research for Best Innovation Award.” His work has had a substantial impact on multiple therapeutic areas, including dermatology, immunology, aesthetic medicine, oncology, and neurology, making him well-deserving of recognition in this prestigious category.